Decreased microglial activation in MS patients treated with glatiramer acetate
- 9 December 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Zeitschrift für Neurologie
- Vol. 259 (6), 1199-1205
- https://doi.org/10.1007/s00415-011-6337-x
Abstract
Activated microglia are thought to be an important contributor to tissue damage in multiple sclerosis (MS). The level of microglial activation can be measured non-invasively using [11C]-R-PK11195, a radiopharmaceutical for positron emission tomography (PET). Prior studies have identified abnormalities in the level of [11C]-R-PK11195 uptake in patients with MS, but treatment effects have not been evaluated. Nine previously untreated relapsing-remitting MS patients underwent PET and magnetic resonance imaging of the brain at baseline and after 1 year of treatment with glatiramer acetate. Parametric maps of [11C]-R-PK11195 uptake were obtained for baseline and post-treatment PET scans, and the change in [11C]-R-PK11195 uptake pre- to post-treatment was evaluated across the whole brain. Region-of-interest analysis was also applied to selected subregions. Whole brain [11C]-R-PK11195 binding potential per unit volume decreased 3.17% (95% CI: −0.74, −5.53%) between baseline and 1 year (p = 0.018). A significant decrease was noted in cortical gray matter and cerebral white matter, and a trend towards decreased uptake was seen in the putamen and thalamus. The results are consistent with a reduction in inflammation due to treatment with glatiramer acetate, though a larger controlled study would be required to prove that association. Future research will focus on whether the level of baseline microglial activation predicts future tissue damage in MS and whether [11C]-R-PK11195 uptake in cortical gray matter correlates with cortical lesion load.Keywords
This publication has 32 references indexed in Scilit:
- Translocator Protein PET Imaging for Glial Activation in Multiple SclerosisJournal of Neuroimmune Pharmacology, 2010
- A topology-preserving approach to the segmentation of brain images with multiple sclerosis lesionsNeuroImage, 2010
- Initial Evaluation of 11C-DPA-713, a Novel TSPO PET Ligand, in HumansJournal of Nuclear Medicine, 2009
- A fast diffeomorphic image registration algorithmNeuroImage, 2007
- Evaluation of Reference Regions for (R)-[11C]PK11195 Studies in Alzheimer's Disease and Mild Cognitive ImpairmentJournal of Cerebral Blood Flow & Metabolism, 2007
- The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: From pathology to imagingProgress in Neurobiology, 2006
- Quantitative Analysis for Estimating Binding Potential of the Peripheral Benzodiazepine Receptor with [11C]DAA1106Journal of Cerebral Blood Flow & Metabolism, 2006
- Axonal Transection in the Lesions of Multiple SclerosisNew England Journal of Medicine, 1998
- Microglia: Intrinsic immuneffector cell of the brainBrain Research Reviews, 1995
- Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitisJournal of Neuroscience Research, 1994